Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis - Concepedia

Concepedia

Publication | Open Access

Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis

DOI Full Paper Access

191

Citations

26

References

2009

Year

Ayalew Tefferi, Srđan Verstovšek, Giovanni Barosi, Francesco Passamonti, Gail J. Roboz, Heinz Gisslinger, Ronald Paquette, Francisco Cervantes, Candido E. Rivera, H. Joachim Deeg,

Journal of Clinical Oncology

Abstract

Pomalidomide therapy at 0.5 or 2 mg/d with or without an abbreviated course of prednisone is well tolerated in patients with myelofibrosis and active in the treatment of anemia.

References

	Year	Citations

Page 1